CETIRIZINE HYDROCHLORIDE ALLERGY

CETIRIZINE HYDROCHLORIDE ALLERGY was reported 31375 times

CETIRIZINE HYDROCHLORIDE ALLERGY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 2017 0.6319
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 404 0.6048
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4239 0.5910
3 RHEUMATIC FEVER 2630 0.5894
4 HEPATIC ENZYME 87 0.5839
5 PEMPHIGUS 7032 0.5619
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1125 0.5617
7 LUPUS VULGARIS 680 0.5397
8 RHEUMATOID FACTOR POSITIVE 3057 0.5287
9 SWOLLEN JOINT COUNT 126 0.5040
10 GRIP STRENGTH 115 0.5022
11 DUODENAL ULCER PERFORATION 3712 0.4987
12 C-REACTIVE PROTEIN 456 0.4919
13 CARDIOSPASM 261 0.4677
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 908 0.4378
15 HAND DEFORMITY 5687 0.4332
16 FACET JOINT SYNDROME 1321 0.4053
17 IMMUNISATION 175 0.4032
18 DISLOCATION OF VERTEBRA 898 0.3933
19 X-RAY ABNORMAL 679 0.3793
20 ANTICIPATORY ANXIETY 98 0.3603
21 HELICOBACTER INFECTION 3663 0.3560
22 PALMOPLANTAR KERATODERMA 255 0.3517
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 189 0.3369
24 RETINITIS 580 0.3355
25 MUSCLE INJURY 2459 0.2965
26 PERICARDITIS 4966 0.2953
27 VAGINAL FLATULENCE 89 0.2937
28 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1897 0.2918
29 GLOSSODYNIA 6533 0.2915
30 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 30 0.2857
31 FOLLICULITIS 2825 0.2691
32 SYNOVITIS 4842 0.2683
33 PERIPHERAL VENOUS DISEASE 1023 0.2502
34 TENDER JOINT COUNT 21 0.2500
35 SERONEGATIVE ARTHRITIS 282 0.2461
36 ALPHA TUMOUR NECROSIS FACTOR INCREASED 22 0.2366
37 URTICARIA THERMAL 33 0.2324
38 BRONCHIAL NEOPLASM 30 0.2206
39 SYSTEMIC LUPUS ERYTHEMATOSUS 7162 0.2016
40 C-REACTIVE PROTEIN ABNORMAL 1257 0.1958
41 WOUND 5477 0.1957
42 CONTRAINDICATED PRODUCT ADMINISTERED 5558 0.1834
43 TEMPERATURE REGULATION DISORDER 398 0.1785
44 HYPOCHOLESTEROLAEMIA 62 0.1756
45 HYPER IGE SYNDROME 20 0.1754
46 BONE EROSION 617 0.1743
47 POST CHOLECYSTECTOMY SYNDROME 49 0.1731
48 PORPHYRIA ACUTE 240 0.1672
49 BREAST CANCER STAGE III 1082 0.1669
50 LIP DRY 1367 0.1504
51 DRUG TOLERANCE DECREASED 417 0.1483
52 GRIP STRENGTH DECREASED 1264 0.1435
53 HYPERCHOLESTEROLAEMIA 1308 0.1353
54 BURSITIS 1637 0.1348
55 ANKLE ARTHROPLASTY 47 0.1295
56 ELECTRIC SHOCK 110 0.1284
57 IRRITABLE BOWEL SYNDROME 2731 0.1272
58 LIVE BIRTH 1061 0.1267
59 ATRIAL TACHYCARDIA 263 0.1251
60 ONYCHOMADESIS 520 0.1238
61 GRANULOCYTE COUNT INCREASED 50 0.1235
62 JOINT RANGE OF MOTION DECREASED 1596 0.1189
63 NAIL OPERATION 49 0.1184
64 WOUND INFECTION 1287 0.1174
65 AUTOIMMUNE DISORDER 1144 0.1172
66 PRURITUS GENITAL 272 0.1154
67 JOINT DESTRUCTION 178 0.1144
68 BLEPHAROSPASM 699 0.1109
69 VOCAL CORD DYSFUNCTION 54 0.1095
70 CHRONIC SPONTANEOUS URTICARIA 124 0.1069
71 LIVER INJURY 2567 0.1045
72 ASPARTATE AMINOTRANSFERASE 25 0.1025
73 LARYNGEAL STENOSIS 59 0.1021
74 FIBROMYALGIA 2472 0.1016
75 ARTHROPATHY 5576 0.1002
76 DEATH NEONATAL 139 0.0999
77 ONYCHOMYCOSIS 423 0.0963
78 BRONCHIAL HAEMORRHAGE 29 0.0929
79 BLOOD IMMUNOGLOBULIN A INCREASED 49 0.0909
80 TYPE 2 DIABETES MELLITUS 2973 0.0882
81 MUSCULOSKELETAL DEFORMITY 20 0.0855
82 INFUSION RELATED REACTION 5618 0.0847
83 IMPAIRED HEALING 2778 0.0845
84 ENDOMETRIAL ABLATION 30 0.0840
85 COELIAC DISEASE 824 0.0839
86 PRESCRIBED OVERDOSE 1604 0.0828
87 OVERLAP SYNDROME 56 0.0800
88 PERFUME SENSITIVITY 45 0.0791
89 MATERNAL EXPOSURE TIMING UNSPECIFIED 295 0.0785
90 HIP ARTHROPLASTY 1200 0.0783
91 DISCOMFORT 4721 0.0773
92 NASAL TURBINATE HYPERTROPHY 29 0.0769
93 SCIATICA 1192 0.0747
94 OBESITY 1174 0.0736
95 FOOD ALLERGY 568 0.0735
96 PSORIATIC ARTHROPATHY 2967 0.0730
97 HEPATIC ENZYME INCREASED 4949 0.0725
98 FINGER DEFORMITY 351 0.0724
99 NAIL DISORDER 629 0.0718
100 RED BLOOD CELL SEDIMENTATION RATE 20 0.0717
101 CAROTID ARTERY OCCLUSION 259 0.0709
102 THERAPEUTIC PRODUCT EFFECT DECREASED 3178 0.0709
103 EXOSTOSIS 646 0.0707
104 RED BLOOD CELL SEDIMENTATION RATE INCREASED 778 0.0702
105 MASTOCYTOSIS 33 0.0698
106 SLEEP TERROR 284 0.0674
107 URINE LEUKOCYTE ESTERASE POSITIVE 47 0.0671
108 WALKING AID USER 439 0.0665
109 RHEUMATOID ARTHRITIS 7475 0.0658
110 SWELLING 6090 0.0650
111 CHRONIC SINUSITIS 242 0.0644
112 TENSION HEADACHE 272 0.0632
113 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 383 0.0629
114 LUPUS-LIKE SYNDROME 568 0.0626
115 LOWER RESPIRATORY TRACT INFECTION 2827 0.0621
116 GLOMERULAR FILTRATION RATE INCREASED 50 0.0605
117 PULMONARY FIBROSIS 1162 0.0605
118 VITAMIN B12 INCREASED 48 0.0602
119 ANAL INFLAMMATION 38 0.0595
120 SARS-COV-2 TEST NEGATIVE 40 0.0593
121 BLOOD CHOLESTEROL INCREASED 2708 0.0580
122 LOWER LIMB FRACTURE 1110 0.0577
123 FEMALE GENITAL TRACT FISTULA 98 0.0573
124 INTERVERTEBRAL DISCITIS 108 0.0572
125 URTICARIA CHRONIC 32 0.0570
126 BLISTER 3205 0.0570
127 PUSTULAR PSORIASIS 190 0.0553
128 PRODUCT LABEL CONFUSION 320 0.0549
129 FOOT DEFORMITY 605 0.0545
130 MATERNAL EXPOSURE DURING PREGNANCY 4865 0.0545
131 DACTYLITIS 53 0.0540
132 KNEE ARTHROPLASTY 1135 0.0539
133 VITAL CAPACITY DECREASED 24 0.0536
134 INFUSION SITE REACTION 159 0.0532
135 DRUG INTOLERANCE 5088 0.0526
136 BREAST CANCER STAGE II 433 0.0520
137 EYE INJURY 157 0.0516
138 FOETAL DEATH 264 0.0509
139 SPONDYLITIS 182 0.0500
140 MACULAR DEGENERATION 595 0.0498
141 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 113 0.0490
142 JOINT DISLOCATION 518 0.0490
143 DRUG TOLERANCE 245 0.0484
144 VICTIM OF CHEMICAL SUBMISSION 32 0.0477
145 CRYSTAL URINE PRESENT 26 0.0468
146 IMMUNODEFICIENCY 683 0.0458
147 PRESCRIBED UNDERDOSE 896 0.0449
148 RHEUMATOID FACTOR INCREASED 50 0.0448
149 GAIT INABILITY 1497 0.0447
150 STOMATITIS 2707 0.0446
151 ABDOMINAL DISCOMFORT 7448 0.0444
152 JOINT SWELLING 5275 0.0437
153 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 313 0.0436
154 TREATMENT FAILURE 3603 0.0434
155 BLOOD IMMUNOGLOBULIN E INCREASED 104 0.0429
156 WHITE BLOOD CELLS URINE POSITIVE 80 0.0425
157 NIGHT SWEATS 1363 0.0423
158 CONGENITAL ANOMALY 326 0.0421
159 URINARY SEDIMENT PRESENT 27 0.0419
160 ULCER HAEMORRHAGE 283 0.0418
161 RASH VESICULAR 201 0.0415
162 INTERLEUKIN LEVEL INCREASED 22 0.0399
163 WHEEZING 2342 0.0395
164 BACK INJURY 424 0.0389
165 ALOPECIA 7541 0.0384
166 ILL-DEFINED DISORDER 2296 0.0378
167 OSTEOARTHRITIS 1574 0.0371
168 EXPOSURE DURING PREGNANCY 2306 0.0371
169 RADICULOPATHY 97 0.0368
170 MOBILITY DECREASED 2594 0.0361
171 HEPATIC CIRRHOSIS 649 0.0345
172 INJURY 2420 0.0344
173 PROCTITIS 95 0.0339
174 MUSCULOSKELETAL STIFFNESS 2964 0.0338
175 RESTRICTIVE PULMONARY DISEASE 39 0.0333
176 C-REACTIVE PROTEIN INCREASED 1210 0.0332
177 TASTE DISORDER 667 0.0328
178 FORCED EXPIRATORY VOLUME DECREASED 90 0.0317
179 INTENTIONAL PRODUCT USE ISSUE 2763 0.0315
180 HYPERSENSITIVITY 5813 0.0313
181 FACIAL PAIN 279 0.0312
182 NEUTROPHIL PERCENTAGE INCREASED 39 0.0309
183 OEDEMA 1677 0.0309
184 NORMAL NEWBORN 167 0.0307
185 POLYARTHRITIS 161 0.0305
186 ASPARTATE AMINOTRANSFERASE ABNORMAL 46 0.0302
187 GENERAL PHYSICAL HEALTH DETERIORATION 3474 0.0300
188 ROAD TRAFFIC ACCIDENT 1251 0.0299
189 SPINAL FUSION SURGERY 121 0.0298
190 LYMPHOCYTE PERCENTAGE DECREASED 40 0.0298
191 INFLAMMATION 1529 0.0296
192 SUBARACHNOID HAEMORRHAGE 299 0.0293
193 RED BLOOD CELLS URINE POSITIVE 28 0.0290
194 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 496 0.0289
195 VASCULAR ACCESS COMPLICATION 23 0.0284
196 DELIRIUM 981 0.0282
197 LIVER DISORDER 1228 0.0277
198 EPILEPSY 844 0.0276
199 PREGNANCY 542 0.0270
200 GASTROINTESTINAL DISORDER 2424 0.0270
201 BRONCHIAL DISORDER 42 0.0270
202 SLEEP DISORDER 1906 0.0270
203 LUNG DISORDER 1322 0.0269
204 TRYPTASE INCREASED 19 0.0266
205 SINUSITIS 2717 0.0265
206 IMMUNISATION REACTION 19 0.0264
207 LIVER FUNCTION TEST INCREASED 562 0.0262
208 EAR PAIN 505 0.0260
209 DEMYELINATION 106 0.0258
210 ALLERGY TO ANIMAL 27 0.0253
211 PRODUCT USE ISSUE 4693 0.0249
212 JOINT NOISE 49 0.0249
213 VASCULITIS 286 0.0245
214 EAR INFECTION 645 0.0242
215 MEAN PLATELET VOLUME DECREASED 20 0.0238
216 PERFORATION 19 0.0236
217 ADRENAL INSUFFICIENCY 285 0.0235
218 THERAPY NON-RESPONDER 1048 0.0233
219 CONTUSION 2240 0.0232
220 MONOCYTE COUNT INCREASED 84 0.0231
221 DRUG-INDUCED LIVER INJURY 713 0.0227
222 ADVERSE REACTION 301 0.0227
223 MUSCULOSKELETAL PAIN 1188 0.0227
224 DRY MOUTH 1835 0.0226
225 JOINT STIFFNESS 593 0.0226
226 GENERAL SYMPTOM 169 0.0225
227 RHONCHI 31 0.0224
228 DUST ALLERGY 22 0.0224
229 URTICARIA 3716 0.0222
230 MAST CELL ACTIVATION SYNDROME 31 0.0221
231 BLOOD PRESSURE DIASTOLIC ABNORMAL 56 0.0220
232 INFECTION 3129 0.0216
233 MYOSITIS 193 0.0215
234 DISABILITY 415 0.0210
235 ASTHMA 2327 0.0206
236 OBSTRUCTIVE AIRWAYS DISORDER 229 0.0206
237 THROAT CLEARING 77 0.0205
238 ANOSMIA 296 0.0204
239 MEAN CELL HAEMOGLOBIN DECREASED 37 0.0202
240 PERIPHERAL SWELLING 3092 0.0201
241 UPPER RESPIRATORY TRACT INFECTION 907 0.0196
242 POST-TRAUMATIC STRESS DISORDER 130 0.0194
243 INFUSION SITE DISCHARGE 34 0.0194
244 MIGRAINE 1846 0.0193
245 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 325 0.0191
246 BLOOD PRESSURE SYSTOLIC ABNORMAL 47 0.0190
247 AMNESIA 1229 0.0189
248 RESPIRATORY DISORDER 559 0.0187
249 MUSCLE SPASTICITY 227 0.0185
250 HYPOAESTHESIA 2708 0.0181
251 PRURITUS ALLERGIC 21 0.0180
252 CONFUSIONAL STATE 2844 0.0176
253 ORAL PRURITUS 40 0.0174
254 DYSPEPSIA 1713 0.0174
255 HYPERTENSION 3649 0.0172
256 NASOPHARYNGITIS 3163 0.0171
257 DRUG USE DISORDER 142 0.0169
258 BACTERIAL TEST POSITIVE 37 0.0166
259 VITAMIN B12 DEFICIENCY 67 0.0165
260 TEMPERATURE INTOLERANCE 168 0.0163
261 RESPIRATORY SYMPTOM 46 0.0162
262 BLOOD PRESSURE DIASTOLIC DECREASED 119 0.0161
263 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1143 0.0161
264 VENTRICULAR TACHYCARDIA 264 0.0160
265 SKIN PLAQUE 133 0.0158
266 HEPATITIS 399 0.0156
267 SUSPECTED OFF LABEL USE 70 0.0155
268 ANGIOEDEMA 680 0.0154
269 RASH 6691 0.0153
270 NASAL DISCHARGE DISCOLOURATION 21 0.0152
271 WEIGHT FLUCTUATION 159 0.0152
272 PARAESTHESIA ORAL 218 0.0151
273 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 720 0.0150
274 BODY TEMPERATURE INCREASED 300 0.0147
275 PAIN 8981 0.0146
276 FREQUENT BOWEL MOVEMENTS 392 0.0145
277 ADVERSE DRUG REACTION 1286 0.0143
278 WEIGHT INCREASED 3203 0.0143
279 MEAN CELL VOLUME DECREASED 22 0.0143
280 INFUSION SITE PRURITUS 45 0.0142
281 SENSITIVITY TO WEATHER CHANGE 75 0.0142
282 POLYCYSTIC OVARIES 22 0.0142
283 LOWER RESPIRATORY TRACT CONGESTION 24 0.0141
284 ALLERGIC REACTION TO EXCIPIENT 28 0.0140
285 OSTEOPOROSIS 571 0.0139
286 PHARYNGEAL PARAESTHESIA 22 0.0139
287 CONDITION AGGRAVATED 4203 0.0138
288 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 111 0.0134
289 BLOOD PRESSURE DIASTOLIC INCREASED 62 0.0134
290 URINE ANALYSIS ABNORMAL 40 0.0134
291 MUSCULAR WEAKNESS 1520 0.0134
292 BLOOD PRESSURE SYSTOLIC INCREASED 260 0.0133
293 ADVERSE EVENT 1223 0.0133
294 FLUID RETENTION 671 0.0132
295 BACK DISORDER 213 0.0131
296 MUSCLE TWITCHING 300 0.0130
297 SCRATCH 137 0.0130
298 ABDOMINAL PAIN UPPER 2655 0.0129
299 SINUS PAIN 30 0.0129
300 MEMORY IMPAIRMENT 1715 0.0125
301 RASH ERYTHEMATOUS 589 0.0123
302 URINE ABNORMALITY 56 0.0123
303 MEDICATION ERROR 680 0.0122
304 EYE PRURITUS 409 0.0122
305 GASTROOESOPHAGEAL REFLUX DISEASE 978 0.0121
306 BLOOD PRESSURE SYSTOLIC DECREASED 55 0.0121
307 LIP SWELLING 402 0.0121
308 ARTHRALGIA 4969 0.0119
309 PAIN OF SKIN 316 0.0117
310 FATIGUE 8943 0.0115
311 PRURITUS 4379 0.0114
312 WHEELCHAIR USER 50 0.0112
313 RHINITIS ALLERGIC 50 0.0112
314 DIPLOPIA 291 0.0112
315 JOINT ARTHROPLASTY 20 0.0112
316 VAGINAL DISCHARGE 113 0.0112
317 PYREXIA 3816 0.0110
318 EAR SWELLING 23 0.0109
319 SYMPTOM RECURRENCE 65 0.0109
320 MIDDLE INSOMNIA 202 0.0108
321 FOOT OPERATION 53 0.0107
322 INFUSION SITE BRUISING 23 0.0106
323 ULCER 160 0.0100
324 CHEST PAIN 1846 0.0100
325 NECK PAIN 553 0.0099
326 ARTHRITIS 776 0.0099
327 FOOD INTOLERANCE 36 0.0098
328 COORDINATION ABNORMAL 137 0.0098
329 MATERNAL EXPOSURE BEFORE PREGNANCY 67 0.0098
330 SEASONAL ALLERGY 137 0.0097
331 RHINITIS 78 0.0097
332 SPUTUM DISCOLOURED 91 0.0096
333 BODY TEMPERATURE DECREASED 94 0.0095
334 PARAESTHESIA 1488 0.0094
335 COLITIS ULCERATIVE 421 0.0094
336 ORAL CANDIDIASIS 124 0.0094
337 PRODUCT USE IN UNAPPROVED INDICATION 2333 0.0094
338 BLOOD URIC ACID INCREASED 54 0.0093
339 DECREASED IMMUNE RESPONSIVENESS 91 0.0093
340 PARANASAL SINUS DISCOMFORT 35 0.0092
341 GRANULOMA 32 0.0092
342 PAPULE 65 0.0092
343 DECREASED APPETITE 2142 0.0092
344 NODULE 120 0.0092
345 CHOLECYSTITIS ACUTE 52 0.0092
346 COGNITIVE DISORDER 428 0.0092
347 RASH PAPULAR 204 0.0091
348 RECTAL HAEMORRHAGE 390 0.0091
349 INSOMNIA 2413 0.0091
350 HYPERTRANSAMINASAEMIA 63 0.0090
351 PERIORBITAL SWELLING 51 0.0090
352 ANXIETY DISORDER 30 0.0090
353 INTENTIONAL PRODUCT MISUSE 783 0.0089
354 BREATH SOUNDS ABNORMAL 44 0.0089
355 INFUSION SITE HAEMORRHAGE 29 0.0088
356 JOINT INJURY 186 0.0087
357 VITAMIN B12 DECREASED 25 0.0087
358 SPINAL DISORDER 82 0.0086
359 EXPIRED PRODUCT ADMINISTERED 286 0.0086
360 JOINT EFFUSION 59 0.0085
361 TRANSIENT ISCHAEMIC ATTACK 288 0.0085
362 GASTROENTERITIS VIRAL 151 0.0084
363 THERAPEUTIC RESPONSE DECREASED 501 0.0083
364 TACHYCARDIA 733 0.0082
365 PULMONARY PAIN 24 0.0082
366 VITAMIN D DEFICIENCY 80 0.0082
367 EYE OEDEMA 20 0.0081
368 HYPERHIDROSIS 1048 0.0081
369 NEUTROPHIL COUNT INCREASED 83 0.0081
370 HEADACHE 5047 0.0080
371 WHITE BLOOD CELL COUNT INCREASED 308 0.0080
372 OEDEMA PERIPHERAL 969 0.0079
373 MALAISE 3485 0.0079
374 ANAPHYLACTIC REACTION 437 0.0079
375 DEPRESSION 1778 0.0078
376 VISUAL IMPAIRMENT 962 0.0078
377 OFF LABEL USE 6778 0.0077
378 MIOSIS 62 0.0077
379 EAR PRURITUS 27 0.0077
380 DISTURBANCE IN ATTENTION 415 0.0077
381 GAIT DISTURBANCE 1468 0.0077
382 TINNITUS 349 0.0076
383 FEELING HOT 464 0.0076
384 SKIN WARM 44 0.0076
385 INJECTION SITE REACTION 520 0.0075
386 MUSCLE SPASMS 1376 0.0075
387 MOUTH SWELLING 43 0.0074
388 ARTHROPOD BITE 55 0.0074
389 UNDERDOSE 538 0.0074
390 NASAL CONGESTION 433 0.0074
391 SKIN LESION 202 0.0074
392 SYNOVIAL CYST 34 0.0074
393 BRONCHITIS 543 0.0073
394 BLINDNESS 298 0.0073
395 PROCTALGIA 47 0.0073
396 PHARYNGEAL SWELLING 71 0.0072
397 DRUG INEFFECTIVE 9562 0.0072
398 WRONG PRODUCT ADMINISTERED 49 0.0072
399 RED CELL DISTRIBUTION WIDTH INCREASED 30 0.0072
400 EXPOSURE TO TOXIC AGENT 23 0.0072
401 PHARYNGITIS 89 0.0072
402 VOMITING 3362 0.0071
403 FULL BLOOD COUNT ABNORMAL 75 0.0071
404 GLOSSITIS 25 0.0070
405 THROAT IRRITATION 314 0.0070
406 LYMPHOCYTE COUNT DECREASED 123 0.0070
407 DYSPNOEA 3926 0.0069
408 NEPHROGENIC ANAEMIA 32 0.0069
409 EOSINOPHILIA 121 0.0069
410 SINUS DISORDER 136 0.0069
411 EOSINOPHIL COUNT INCREASED 57 0.0068
412 PNEUMONIA 2208 0.0068
413 TONGUE OEDEMA 26 0.0068
414 ELECTRIC SHOCK SENSATION 19 0.0068
415 PRODUCT ADMINISTRATION INTERRUPTED 53 0.0067
416 PSORIASIS 879 0.0067
417 PRE-EXISTING CONDITION IMPROVED 42 0.0067
418 WOUND COMPLICATION 23 0.0067
419 PAIN IN EXTREMITY 1964 0.0067
420 ATTENTION DEFICIT HYPERACTIVITY DISORDER 28 0.0066
421 OROPHARYNGEAL DISCOMFORT 60 0.0066
422 BLOOD PRESSURE FLUCTUATION 159 0.0066
423 SKIN ABRASION 31 0.0066
424 ANXIETY 1858 0.0065
425 ABDOMINAL PAIN 1513 0.0065
426 PROCEDURAL PAIN 179 0.0064
427 DIZZINESS 3203 0.0064
428 LABORATORY TEST ABNORMAL 189 0.0064
429 WEIGHT DECREASED 1784 0.0064
430 MULTIPLE ALLERGIES 50 0.0064
431 BLOOD TEST ABNORMAL 89 0.0063
432 PIGMENTATION DISORDER 39 0.0063
433 PRODUCTIVE COUGH 300 0.0063
434 HEART RATE INCREASED 608 0.0061
435 SOMNAMBULISM 40 0.0061
436 SINUS CONGESTION 82 0.0061
437 ABDOMINAL TENDERNESS 30 0.0060
438 INFUSION SITE SWELLING 38 0.0060
439 LIMB DISCOMFORT 184 0.0059
440 SECRETION DISCHARGE 74 0.0059
441 IMMUNE THROMBOCYTOPENIA 27 0.0059
442 SINUS HEADACHE 35 0.0059
443 PORTAL VEIN THROMBOSIS 19 0.0059
444 INFUSION SITE EXTRAVASATION 36 0.0058
445 STREPTOCOCCAL INFECTION 32 0.0057
446 ASTHENIA 2158 0.0057
447 DYSPHEMIA 25 0.0057
448 ABDOMINAL DISTENSION 593 0.0057
449 MATERNAL EXPOSURE DURING BREAST FEEDING 23 0.0057
450 INCORRECT DRUG ADMINISTRATION RATE 24 0.0056
451 INFUSION SITE PAIN 72 0.0056
452 INCORRECT PRODUCT ADMINISTRATION DURATION 121 0.0056
453 SKIN REACTION 78 0.0055
454 BACK PAIN 1282 0.0055
455 APHONIA 77 0.0055
456 HYPOCALCAEMIA 104 0.0055
457 PULMONARY FUNCTION TEST DECREASED 24 0.0055
458 THERAPEUTIC PRODUCT EFFECT DELAYED 25 0.0055
459 THERAPY PARTIAL RESPONDER 85 0.0054
460 PANCREATITIS 287 0.0054
461 DIARRHOEA 3499 0.0054
462 FOOD POISONING 29 0.0054
463 THERAPEUTIC PRODUCT EFFECT VARIABLE 21 0.0054
464 DRUG EFFECT LESS THAN EXPECTED 79 0.0053
465 ERYTHEMA 1092 0.0053
466 NASAL POLYPS 26 0.0053
467 SNEEZING 118 0.0053
468 BRONCHIECTASIS 35 0.0052
469 ROSACEA 24 0.0051
470 DYSLIPIDAEMIA 26 0.0051
471 AFFECTIVE DISORDER 40 0.0051
472 THROMBOCYTOPENIA 569 0.0051
473 GASTROENTERITIS 74 0.0051
474 NAUSEA 3980 0.0050
475 RHINORRHOEA 324 0.0050
476 OROPHARYNGEAL PAIN 464 0.0050
477 OBSTRUCTION 20 0.0050
478 EYE SWELLING 185 0.0050
479 HALLUCINATION 373 0.0049
480 NASAL DRYNESS 31 0.0049
481 RETCHING 105 0.0049
482 INFUSION SITE ERYTHEMA 41 0.0049
483 PALPITATIONS 566 0.0048
484 POOR VENOUS ACCESS 50 0.0048
485 FRUSTRATION TOLERANCE DECREASED 39 0.0048
486 RASH PRURITIC 261 0.0048
487 HEPATIC ENZYME ABNORMAL 24 0.0048
488 OXYGEN SATURATION DECREASED 270 0.0048
489 TONGUE DISCOLOURATION 21 0.0048
490 CYTOKINE RELEASE SYNDROME 96 0.0048
491 ACCIDENT 57 0.0048
492 SLEEP APNOEA SYNDROME 91 0.0048
493 HYPOKALAEMIA 220 0.0048
494 BREAST CANCER STAGE I 44 0.0047
495 DERMATITIS CONTACT 54 0.0047
496 DEPRESSED MOOD 247 0.0047
497 ILLNESS 474 0.0046
498 CHEST DISCOMFORT 470 0.0046
499 SOCIAL PROBLEM 19 0.0046
500 COVID-19 805 0.0046
501 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 250 0.0046
502 PHYSICAL DISABILITY 20 0.0045
503 RESPIRATORY RATE INCREASED 40 0.0045
504 RESPIRATORY TRACT INFECTION 117 0.0045
505 UPPER-AIRWAY COUGH SYNDROME 37 0.0045
506 ASPIRATION 49 0.0045
507 SARS-COV-2 TEST POSITIVE 59 0.0045
508 PHARYNGITIS STREPTOCOCCAL 48 0.0044
509 INJECTION SITE INFLAMMATION 22 0.0044
510 DERMATITIS EXFOLIATIVE 22 0.0044
511 THERAPEUTIC RESPONSE SHORTENED 143 0.0043
512 ECZEMA 224 0.0043
513 BRAIN FOG 67 0.0043
514 SWELLING FACE 277 0.0042
515 VASCULAR DEVICE INFECTION 19 0.0042
516 SKIN HAEMORRHAGE 62 0.0042
517 DRY EYE 208 0.0042
518 FLANK PAIN 39 0.0042
519 SOMNOLENCE 836 0.0041
520 PRODUCT QUALITY ISSUE 562 0.0041
521 BRONCHOSPASM 59 0.0041
522 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 744 0.0041
523 BLOOD PRESSURE INCREASED 631 0.0041
524 THROAT TIGHTNESS 111 0.0041
525 EXTRA DOSE ADMINISTERED 166 0.0041
526 CONJUNCTIVITIS 76 0.0041
527 DYSPHAGIA 387 0.0041
528 BLOOD UREA INCREASED 68 0.0041
529 LIGAMENT SPRAIN 40 0.0040
530 HEART RATE DECREASED 142 0.0040
531 POOR QUALITY SLEEP 87 0.0040
532 ANAPHYLACTIC SHOCK 104 0.0040
533 FACE OEDEMA 68 0.0040
534 RESPIRATORY SYNCYTIAL VIRUS INFECTION 35 0.0040
535 SKIN INFECTION 45 0.0040
536 RESPIRATORY TRACT CONGESTION 63 0.0040
537 COUGH 1107 0.0039
538 VIRAL INFECTION 131 0.0039
539 FOETAL EXPOSURE DURING PREGNANCY 320 0.0039
540 PHOTOSENSITIVITY REACTION 65 0.0039
541 OVERDOSE 846 0.0039
542 SENSATION OF FOREIGN BODY 33 0.0039
543 BRUXISM 21 0.0039
544 SWOLLEN TONGUE 121 0.0039
545 APHTHOUS ULCER 30 0.0039
546 ERYTHEMA MULTIFORME 36 0.0039
547 LEUKOPENIA 193 0.0039
548 SENSORY LOSS 31 0.0038
549 POSTOPERATIVE WOUND INFECTION 26 0.0038
550 TENDERNESS 40 0.0038
551 TENDON DISORDER 25 0.0038
552 HYPERVENTILATION 22 0.0038
553 LACRIMATION INCREASED 114 0.0038
554 INFLUENZA 420 0.0038
555 HEART RATE ABNORMAL 21 0.0038
556 GINGIVAL BLEEDING 51 0.0037
557 DYSPHONIA 216 0.0037
558 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 25 0.0037
559 MUSCULOSKELETAL DISCOMFORT 63 0.0037
560 DERMATITIS ALLERGIC 46 0.0037
561 CHOKING SENSATION 20 0.0036
562 RALES 21 0.0036
563 ACCIDENTAL OVERDOSE 132 0.0036
564 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 28 0.0036
565 BLOOD URINE PRESENT 68 0.0036
566 HEPATIC CYTOLYSIS 45 0.0035
567 DRY SKIN 471 0.0035
568 RASH MACULAR 123 0.0035
569 LIMB INJURY 95 0.0035
570 ANKLE FRACTURE 54 0.0035
571 DRY THROAT 35 0.0034
572 CONSTIPATION 751 0.0034
573 RED BLOOD CELL COUNT DECREASED 98 0.0034
574 BREAST MASS 23 0.0034
575 RASH MACULO-PAPULAR 76 0.0034
576 MULTIPLE SCLEROSIS 163 0.0034
577 HEPATITIS ACUTE 22 0.0034
578 NERVE COMPRESSION 31 0.0034
579 CONCUSSION 26 0.0034
580 RESTLESS LEGS SYNDROME 61 0.0034
581 ALANINE AMINOTRANSFERASE INCREASED 205 0.0033
582 DYSPNOEA EXERTIONAL 125 0.0033
583 PAROSMIA 25 0.0033
584 DIZZINESS POSTURAL 32 0.0033
585 SKIN MASS 22 0.0033
586 EYE DISORDER 108 0.0033
587 HEAD DISCOMFORT 58 0.0033
588 TOOTH FRACTURE 36 0.0033
589 BLOOD ALKALINE PHOSPHATASE INCREASED 81 0.0033
590 SENSITIVE SKIN 24 0.0032
591 FEELING OF BODY TEMPERATURE CHANGE 19 0.0032
592 FEELING COLD 90 0.0032
593 ORAL HERPES 63 0.0032
594 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
595 FEELING JITTERY 61 0.0032
596 RESPIRATION ABNORMAL 22 0.0032
597 COLITIS 121 0.0032
598 HAEMORRHOIDS 62 0.0032
599 SINUS TACHYCARDIA 45 0.0032
600 FEELING ABNORMAL 756 0.0032
601 EYE INFLAMMATION 30 0.0031
602 HAEMATOCHEZIA 173 0.0031
603 PRODUCT AVAILABILITY ISSUE 71 0.0031
604 MUSCLE TIGHTNESS 50 0.0031
605 PLATELET COUNT INCREASED 40 0.0031
606 TOOTH ABSCESS 31 0.0030
607 BLOOD THYROID STIMULATING HORMONE INCREASED 28 0.0030
608 IRON DEFICIENCY ANAEMIA 28 0.0030
609 WRONG DRUG ADMINISTERED 27 0.0030
610 SWELLING OF EYELID 19 0.0030
611 SEPTIC SHOCK 131 0.0030
612 ATELECTASIS 29 0.0030
613 WITHDRAWAL SYNDROME 126 0.0030
614 MICTURITION URGENCY 34 0.0030
615 ASPARTATE AMINOTRANSFERASE INCREASED 158 0.0030
616 POISONING 37 0.0029
617 SENSORY DISTURBANCE 47 0.0029
618 DEHYDRATION 390 0.0029
619 SCAB 33 0.0029
620 FORMICATION 20 0.0029
621 MOVEMENT DISORDER 92 0.0029
622 HYPERSOMNIA 82 0.0029
623 FOOT FRACTURE 54 0.0028
624 FALL 946 0.0028
625 QUALITY OF LIFE DECREASED 38 0.0028
626 PURPURA 25 0.0028
627 HYPOKINESIA 41 0.0028
628 HAEMATOCRIT DECREASED 56 0.0028
629 BALANCE DISORDER 244 0.0028
630 FEAR OF INJECTION 20 0.0028
631 BLOOD PRESSURE DECREASED 186 0.0028
632 INTERVERTEBRAL DISC PROTRUSION 61 0.0028
633 DEFORMITY 26 0.0028
634 CHOKING 54 0.0028
635 SKIN SWELLING 24 0.0028
636 INFLAMMATORY BOWEL DISEASE 27 0.0028
637 HEART RATE IRREGULAR 62 0.0027
638 APPETITE DISORDER 18 0.0027
639 NEURALGIA 66 0.0027
640 PLEURAL EFFUSION 165 0.0027
641 DUODENAL ULCER 19 0.0027
642 FEELING DRUNK 20 0.0027
643 GLOMERULAR FILTRATION RATE DECREASED 33 0.0027
644 PETECHIAE 28 0.0027
645 TOOTH INFECTION 35 0.0027
646 HYPOTENSION 531 0.0026
647 AGEUSIA 66 0.0026
648 CHILLS 309 0.0026
649 TOXIC EPIDERMAL NECROLYSIS 40 0.0026
650 EAR DISCOMFORT 27 0.0026
651 LYMPHOPENIA 37 0.0026
652 KIDNEY INFECTION 51 0.0026
653 EYE DISCHARGE 27 0.0026
654 SYNCOPE 260 0.0026
655 ORAL DISORDER 19 0.0026
656 PSYCHOMOTOR HYPERACTIVITY 43 0.0026
657 HOSPITALISATION 397 0.0026
658 MASS 36 0.0026
659 LOSS OF CONSCIOUSNESS 329 0.0026
660 ABNORMAL FAECES 21 0.0026
661 PHOTOPHOBIA 48 0.0025
662 HERPES ZOSTER 146 0.0025
663 COVID-19 PNEUMONIA 30 0.0025
664 PHARYNGEAL OEDEMA 39 0.0025
665 DECREASED ACTIVITY 27 0.0025
666 GLYCOSYLATED HAEMOGLOBIN INCREASED 63 0.0025
667 MYDRIASIS 32 0.0025
668 ROTATOR CUFF SYNDROME 32 0.0025
669 HYPERTHERMIA 19 0.0025
670 BOWEL MOVEMENT IRREGULARITY 19 0.0025
671 PRESYNCOPE 60 0.0025
672 PNEUMONITIS 67 0.0025
673 SCAR 42 0.0025
674 SLUGGISHNESS 25 0.0024
675 CYSTITIS 78 0.0024
676 DERMATITIS ATOPIC 129 0.0024
677 VERTIGO 148 0.0024
678 WRIST FRACTURE 29 0.0024
679 DRUG EXPOSURE DURING PREGNANCY 82 0.0024
680 PARANOIA 41 0.0024
681 HYPOMAGNESAEMIA 33 0.0024
682 TREATMENT NONCOMPLIANCE 129 0.0024
683 INSURANCE ISSUE 36 0.0024
684 TACHYPNOEA 32 0.0024
685 POST PROCEDURAL INFECTION 19 0.0023
686 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 60 0.0023
687 ABSCESS 37 0.0023
688 PRURITUS GENERALISED 50 0.0023
689 NEUROPATHY PERIPHERAL 217 0.0023
690 DIVERTICULITIS 63 0.0023
691 URINARY TRACT INFECTION 385 0.0023
692 EATING DISORDER 48 0.0023
693 NIGHTMARE 78 0.0023
694 THINKING ABNORMAL 42 0.0023
695 FUNGAL INFECTION 75 0.0022
696 SKIN DISORDER 75 0.0022
697 INTENTIONAL DOSE OMISSION 64 0.0022
698 THIRST 40 0.0022
699 PARALYSIS 32 0.0022
700 FLUSHING 227 0.0022
701 PRODUCT DOSE OMISSION ISSUE 652 0.0022
702 PSEUDOMONAS INFECTION 19 0.0022
703 POISONING DELIBERATE 21 0.0022
704 ABORTION SPONTANEOUS 88 0.0022
705 BLOOD IRON DECREASED 26 0.0022
706 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 64 0.0022
707 HYPONATRAEMIA 123 0.0022
708 GENERALISED OEDEMA 27 0.0022
709 DYSARTHRIA 82 0.0022
710 UROSEPSIS 20 0.0022
711 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
712 IMPAIRED QUALITY OF LIFE 31 0.0022
713 PRODUCT DISTRIBUTION ISSUE 20 0.0022
714 HEPATIC STEATOSIS 40 0.0021
715 INCORRECT DOSE ADMINISTERED 490 0.0021
716 OCULAR HYPERAEMIA 101 0.0021
717 IMPAIRED GASTRIC EMPTYING 29 0.0021
718 PULMONARY CONGESTION 28 0.0021
719 GASTROINTESTINAL INFECTION 19 0.0021
720 DYSURIA 78 0.0021
721 HEPATOCELLULAR INJURY 30 0.0021
722 PANIC ATTACK 77 0.0021
723 FEBRILE NEUTROPENIA 139 0.0021
724 LYMPHADENOPATHY 74 0.0021
725 END STAGE RENAL DISEASE 38 0.0021
726 FEEDING DISORDER 42 0.0021
727 CHRONIC KIDNEY DISEASE 157 0.0021
728 CATARACT 123 0.0021
729 GOUT 37 0.0021
730 SEIZURE 236 0.0020
731 BLOOD GLUCOSE INCREASED 384 0.0020
732 SKIN LACERATION 22 0.0020
733 RESTLESSNESS 74 0.0020
734 URINARY RETENTION 67 0.0020
735 ANAL INCONTINENCE 18 0.0020
736 GASTROINTESTINAL PAIN 22 0.0020
737 HYPOAESTHESIA ORAL 30 0.0020
738 TOXIC SKIN ERUPTION 20 0.0020
739 STEVENS-JOHNSON SYNDROME 44 0.0020
740 PRODUCT DOSE OMISSION IN ERROR 56 0.0020
741 DRUG ERUPTION 35 0.0020
742 PRODUCT PRESCRIBING ERROR 47 0.0020
743 EYE PAIN 111 0.0020
744 MYOCARDIAL INFARCTION 343 0.0020
745 OCULAR DISCOMFORT 22 0.0020
746 BURNING SENSATION 137 0.0020
747 SPEECH DISORDER 102 0.0019
748 THYROID DISORDER 30 0.0019
749 SKIN DISCOLOURATION 89 0.0019
750 INJECTION SITE DISCOMFORT 20 0.0019
751 CANDIDA INFECTION 32 0.0019
752 INJECTION SITE IRRITATION 24 0.0019
753 BLOOD CREATININE INCREASED 123 0.0019
754 BREAST PAIN 20 0.0019
755 TENDONITIS 29 0.0019
756 SEDATION 49 0.0019
757 CARDIOMEGALY 23 0.0019
758 HAEMOPTYSIS 52 0.0019
759 ANGER 63 0.0019
760 DIABETES MELLITUS 142 0.0019
761 BLOOD POTASSIUM DECREASED 56 0.0019
762 LOCALISED INFECTION 45 0.0019
763 EYE INFECTION 21 0.0019
764 MYALGIA 315 0.0019
765 MOUTH ULCERATION 39 0.0018
766 HEPATOTOXICITY 41 0.0018
767 AGITATION 135 0.0018
768 PULMONARY THROMBOSIS 20 0.0018
769 MOOD ALTERED 50 0.0018
770 LETHARGY 105 0.0018
771 POLLAKIURIA 76 0.0018
772 IMMUNE SYSTEM DISORDER 24 0.0018
773 ABDOMINAL PAIN LOWER 46 0.0018
774 CRYING 66 0.0018
775 DRUG ABUSE 151 0.0018
776 BLOOD PRESSURE ABNORMAL 36 0.0018
777 SUICIDAL IDEATION 165 0.0018
778 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94 0.0018
779 HEAD INJURY 57 0.0018
780 SUICIDE ATTEMPT 109 0.0018
781 INCONTINENCE 19 0.0018
782 BONE LOSS 27 0.0018
783 EYE IRRITATION 103 0.0018
784 URINARY INCONTINENCE 53 0.0018
785 FEAR 48 0.0018
786 ABNORMAL WEIGHT GAIN 22 0.0018
787 HOT FLUSH 134 0.0018
788 HIATUS HERNIA 23 0.0018
789 CYST 22 0.0018
790 CHOLECYSTITIS 21 0.0018
791 NERVOUSNESS 92 0.0018
792 BONE PAIN 103 0.0018
793 RIB FRACTURE 36 0.0017
794 CELLULITIS 88 0.0017
795 PULMONARY MASS 26 0.0017
796 CHOLESTASIS 33 0.0017
797 TOOTHACHE 31 0.0017
798 BLOOD SODIUM DECREASED 32 0.0017
799 PALLOR 46 0.0017
800 CHROMATURIA 38 0.0017
801 REBOUND EFFECT 19 0.0017
802 INFLUENZA LIKE ILLNESS 138 0.0017
803 PERIPHERAL COLDNESS 23 0.0017
804 INJECTION SITE URTICARIA 41 0.0017
805 BRAIN OEDEMA 21 0.0017
806 EPISTAXIS 124 0.0017
807 TUBULOINTERSTITIAL NEPHRITIS 31 0.0017
808 CLOSTRIDIUM DIFFICILE INFECTION 36 0.0016
809 BLOOD GLUCOSE DECREASED 79 0.0016
810 TREMOR 273 0.0016
811 CARPAL TUNNEL SYNDROME 23 0.0016
812 THERAPEUTIC RESPONSE UNEXPECTED 73 0.0016
813 DRUG INTERACTION 257 0.0016
814 UPPER LIMB FRACTURE 32 0.0016
815 DISEASE RECURRENCE 76 0.0016
816 HYPOTHYROIDISM 51 0.0016
817 IRRITABILITY 96 0.0016
818 PRODUCT ADMINISTRATION ERROR 32 0.0016
819 TOOTH DISORDER 35 0.0016
820 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 318 0.0016
821 INJECTION SITE PRURITUS 105 0.0016
822 BRADYCARDIA 83 0.0016
823 GASTRITIS 41 0.0016
824 GLAUCOMA 30 0.0016
825 NEPHROLITHIASIS 71 0.0015
826 INJECTION SITE SWELLING 118 0.0015
827 BASAL CELL CARCINOMA 24 0.0015
828 ANKYLOSING SPONDYLITIS 20 0.0015
829 BLOOD COUNT ABNORMAL 23 0.0015
830 WHITE BLOOD CELL COUNT DECREASED 164 0.0015
831 MOOD SWINGS 48 0.0015
832 HYPOXIA 53 0.0015
833 BACTERIAL INFECTION 28 0.0015
834 AGGRESSION 75 0.0015
835 MALIGNANT MELANOMA 20 0.0015
836 COMA 71 0.0015
837 PNEUMONIA ASPIRATION 37 0.0015
838 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
839 ORAL PAIN 33 0.0015
840 NO ADVERSE EVENT 266 0.0015
841 ANAEMIA 280 0.0015
842 HAEMATOMA 38 0.0015
843 MANIA 24 0.0015
844 GALLBLADDER DISORDER 26 0.0015
845 DRUG LEVEL INCREASED 24 0.0014
846 COMPLICATION ASSOCIATED WITH DEVICE 21 0.0014
847 PANCREATITIS ACUTE 32 0.0014
848 ACUTE KIDNEY INJURY 217 0.0014
849 INCREASED APPETITE 27 0.0014
850 ABNORMAL DREAMS 39 0.0014
851 SKIN EXFOLIATION 119 0.0014
852 DYSGEUSIA 103 0.0014
853 DERMATITIS 29 0.0014
854 SKIN FISSURES 27 0.0014
855 HYPERTHYROIDISM 20 0.0014
856 HUNGER 19 0.0014
857 MUSCULOSKELETAL CHEST PAIN 21 0.0014
858 DRUG EFFECT DECREASED 73 0.0014
859 INTESTINAL OBSTRUCTION 51 0.0014
860 ACUTE RESPIRATORY FAILURE 26 0.0014
861 NEUTROPHIL COUNT DECREASED 55 0.0013
862 DRUG EFFECT INCOMPLETE 49 0.0013
863 MENTAL DISORDER 58 0.0013
864 GENERALISED TONIC-CLONIC SEIZURE 22 0.0013
865 INTENTIONAL OVERDOSE 85 0.0013
866 OSTEOPENIA 20 0.0013
867 COLD SWEAT 23 0.0013
868 JAUNDICE 35 0.0013
869 DELUSION 20 0.0013
870 HYPOGLYCAEMIA 62 0.0013
871 INJECTION SITE WARMTH 26 0.0013
872 DISORIENTATION 50 0.0013
873 APHASIA 38 0.0013
874 RENAL DISORDER 58 0.0012
875 SKIN IRRITATION 57 0.0012
876 HEMIPARESIS 21 0.0012
877 HYPERKALAEMIA 43 0.0012
878 VISION BLURRED 168 0.0012
879 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
880 INJECTION SITE MASS 45 0.0012
881 IMPAIRED WORK ABILITY 26 0.0012
882 INJECTION SITE BRUISING 96 0.0012
883 SEROTONIN SYNDROME 23 0.0012
884 DRUG DEPENDENCE 192 0.0012
885 INJECTION SITE ERYTHEMA 148 0.0012
886 INTENTIONAL SELF-INJURY 24 0.0012
887 HAEMOGLOBIN DECREASED 122 0.0012
888 HALLUCINATION, VISUAL 25 0.0012
889 AGRANULOCYTOSIS 22 0.0012
890 STAPHYLOCOCCAL INFECTION 39 0.0012
891 PLATELET COUNT DECREASED 126 0.0012
892 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
893 BLOOD POTASSIUM INCREASED 19 0.0012
894 NEEDLE ISSUE 34 0.0012
895 DYSSTASIA 34 0.0012
896 MUSCULOSKELETAL DISORDER 22 0.0012
897 ACNE 87 0.0011
898 FLATULENCE 65 0.0011
899 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
900 ERECTILE DYSFUNCTION 29 0.0011
901 CHOLELITHIASIS 37 0.0011
902 CORONARY ARTERY DISEASE 34 0.0011
903 PAIN IN JAW 31 0.0011
904 NEUTROPENIA 148 0.0011
905 ERUCTATION 21 0.0011
906 SKIN ULCER 28 0.0011
907 DYSTONIA 21 0.0011
908 EMOTIONAL DISTRESS 131 0.0011
909 TRANSAMINASES INCREASED 24 0.0011
910 SKIN BURNING SENSATION 77 0.0011
911 DYSKINESIA 43 0.0011
912 INTERSTITIAL LUNG DISEASE 51 0.0011
913 PULMONARY OEDEMA 47 0.0010
914 SPINAL FRACTURE 21 0.0010
915 INJECTION SITE RASH 32 0.0010
916 TARDIVE DYSKINESIA 29 0.0010
917 HYPOACUSIS 44 0.0010
918 RENAL FAILURE 134 0.0010
919 UNRESPONSIVE TO STIMULI 26 0.0010
920 INJECTION SITE PAIN 309 0.0010
921 RENAL IMPAIRMENT 84 0.0010
922 GASTRIC ULCER 19 0.0010
923 LIVER FUNCTION TEST ABNORMAL 29 0.0010
924 TOXICITY TO VARIOUS AGENTS 166 0.0010
925 CARDIAC FAILURE 78 0.0010
926 BLOOD BILIRUBIN INCREASED 26 0.0010
927 ANGINA PECTORIS 27 0.0009
928 FAECES DISCOLOURED 20 0.0009
929 SURGERY 53 0.0009
930 PRODUCT SUBSTITUTION ISSUE 52 0.0009
931 ENCEPHALOPATHY 22 0.0009
932 SKIN CANCER 19 0.0009
933 PSYCHOTIC DISORDER 26 0.0009
934 DEAFNESS 23 0.0009
935 HYPERGLYCAEMIA 32 0.0009
936 GASTRIC DISORDER 30 0.0009
937 ATRIAL FIBRILLATION 85 0.0009
938 NERVOUS SYSTEM DISORDER 27 0.0009
939 THERAPY INTERRUPTED 61 0.0009
940 CARDIAC DISORDER 79 0.0008
941 EMOTIONAL DISORDER 26 0.0008
942 MUCOSAL INFLAMMATION 22 0.0008
943 CARDIO-RESPIRATORY ARREST 35 0.0008
944 CARDIAC ARREST 69 0.0008
945 HEPATIC FUNCTION ABNORMAL 31 0.0008
946 ARRHYTHMIA 39 0.0008
947 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
948 MULTIPLE SCLEROSIS RELAPSE 55 0.0008
949 PULMONARY EMBOLISM 75 0.0008
950 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
951 RENAL INJURY 23 0.0008
952 LACTIC ACIDOSIS 25 0.0008
953 CARDIAC FAILURE CONGESTIVE 62 0.0008
954 THROMBOSIS 62 0.0008
955 PANCYTOPENIA 43 0.0008
956 HEPATIC FAILURE 23 0.0008
957 RESPIRATORY DISTRESS 21 0.0008
958 ABNORMAL BEHAVIOUR 30 0.0008
959 DEMENTIA 21 0.0008
960 INJECTION SITE HAEMORRHAGE 60 0.0008
961 HIP FRACTURE 24 0.0007
962 HAEMORRHAGE 78 0.0007
963 HYPOPHAGIA 19 0.0007
964 RESPIRATORY FAILURE 54 0.0007
965 MENSTRUATION IRREGULAR 19 0.0007
966 DEEP VEIN THROMBOSIS 46 0.0007
967 BONE DENSITY DECREASED 22 0.0007
968 HAEMATURIA 24 0.0007
969 SEPSIS 78 0.0007
970 LUNG NEOPLASM MALIGNANT 28 0.0007
971 COMPLETED SUICIDE 56 0.0007
972 VAGINAL HAEMORRHAGE 29 0.0007
973 ACCIDENTAL EXPOSURE TO PRODUCT 66 0.0006
974 UNEVALUABLE EVENT 48 0.0006
975 CEREBROVASCULAR ACCIDENT 106 0.0006
976 DRUG WITHDRAWAL SYNDROME 54 0.0006
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 42 0.0006
978 NEOPLASM MALIGNANT 38 0.0006
979 RHABDOMYOLYSIS 23 0.0006
980 THERAPY CESSATION 28 0.0005
981 PLASMA CELL MYELOMA 21 0.0005
982 GASTROINTESTINAL HAEMORRHAGE 43 0.0005
983 DEATH 443 0.0005
984 CONVULSION 26 0.0005
985 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
986 DISEASE PROGRESSION 39 0.0003
987 BREAST CANCER 28 0.0003
988 DEVICE ISSUE 26 0.0003
989 PRODUCT STORAGE ERROR 21 0.0002
990 DRUG DOSE OMISSION 24 0.0001